FDA mulls subjecting metal hip implants to tougher oversight

01/18/2013 | Reuters · Wall Street Journal, The

The FDA has proposed requiring makers of metal-on-metal hip implants to submit additional data to back the safety and effectiveness of their devices in order to continue marketing them. The move is spurred by concerns that the devices can lead to soft-tissue damage and may require replacement surgery.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC